Lenovo Unveils Eye-Tracking Device for ALS Patients

0
10


Rongchai Wang
Oct 18, 2024 04:07

Lenovo launches a new eye-tracking device aimed at enhancing accessibility for ALS patients, integrating advanced AI technologies for improved communication.





Lenovo has announced the launch of an innovative eye-tracking device designed to enhance accessibility for individuals with Amyotrophic Lateral Sclerosis (ALS), according to ElevenLabs. This new technology aims to empower ALS patients by providing them with advanced tools for communication.

Advancements in Voice AI Technology

During the launch event, Erin Taylor, a disability advocate with ALS, demonstrated the device’s capabilities by introducing Lenovo’s Chairman. This technology allows users to communicate using their own voices, a significant improvement over previous voice banking methods that often lacked emotional depth. By leveraging advanced voice AI, users can now recreate their unique vocal tones and maintain their personal identity.

Collaboration with Key Partners

Lenovo’s eye-tracking device incorporates avatars from D-ID and precise eye-tracking technology from IrisBond, making it both accessible and user-friendly. ElevenLabs, known for its advanced voice AI solutions, is a key partner in this project. The collaboration aims to help ALS patients regain their voices and communicate authentically.

Continuing a Legacy of Innovation

This development aligns with the vision of Dr. Peter Scott-Morgan, who advocated for using technology to eliminate barriers for individuals with severe disabilities. Thanks to recent technological advances, this vision is becoming a reality, offering new hope and possibilities for ALS patients.

Ongoing Development and Testing

The project continues under the stewardship of the Scott-Morgan Foundation (SMF), which is committed to refining the tool to ensure it meets the real-world needs of ALS patients. By continuously testing and improving the device, SMF aims to make a tangible difference in the lives of those affected by ALS.

For more information, visit the original article on ElevenLabs.

Image source: Shutterstock


Credit: Source link

ads

LEAVE A REPLY

Please enter your comment!
Please enter your name here